CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 163 filers reported holding CLOVIS ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $71,000 | -28.3% | 60,000 | +9.1% | 0.03% | -22.9% |
| Q2 2022 | $99,000 | +54.7% | 55,000 | +71.9% | 0.04% | +75.0% |
| Q1 2022 | $64,000 | -21.0% | 32,000 | +6.7% | 0.02% | -23.1% |
| Q4 2021 | $81,000 | -32.5% | 30,000 | +11.1% | 0.03% | -36.6% |
| Q3 2021 | $120,000 | -31.0% | 27,000 | -10.0% | 0.04% | -26.8% |
| Q2 2021 | $174,000 | +24.3% | 30,000 | +50.0% | 0.06% | +19.1% |
| Q1 2021 | $140,000 | +145.6% | 20,000 | +66.7% | 0.05% | +123.8% |
| Q4 2020 | $57,000 | -1.7% | 12,000 | +20.0% | 0.02% | -16.0% |
| Q3 2020 | $58,000 | – | 10,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |